Guidance For Industry Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects
Contains Nonbinding Recommendations
TABLE OF CONTENTS
I. INTRODUCTION
II. OVERVIEW OF INVESTIGATOR RESPONSIBILITIES
III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES
A. Supervision of the Conduct of a Clinical Investigation
1. What Is Appropriate Delegation of Study-Related Tasks?
2. What Is Adequate Training?
3. What Is Adequate Supervision of the Conduct of an Ongoing Clinical Trial?
4. What Are an Investigator’s Responsibilities for Oversight of Other Parties Involved in the Conduct of a Clinical Trial?
B. Protecting the Rights, Safety, and Welfare of Study Subjects
1. Reasonable Medical Care Necessitated by Participation in a Clinical Trial.
2. Reasonable Access to Medical Care.
3. Protocol Violations that Present Unreasonable Risks.
ATTACHMENT A: COPY OF FORM 1572.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm or
Office of Communication, Training and Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
http://www.fda.gov/cber/guidelines.htm (Tel) 800-835-4709 or 301-827-1800 or
Office of Health and Industry Programs
Division of Small Manufacturers, International, and Consumer Assistance, HFZ-220
Center for Devices and Radiological Health
Food and Drug Administration
Tel: 1-800-638-2041
http://www.fda.gov/cdrh U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Procedural
October 2009
Clinical Research News
Upcoming Clinical Trials
-
Ruijin HospitalJiangsu HengRui Medicine Co., Ltd.Recruiting
-
National Taiwan University HospitalMin-Sheng General Hospital; Ministry of Health and Welfare, Taiwan; Fu Jen Catholic...Not yet recruitingAge-Related Macular Degeneration (AMD) | Diabetic Retinopathy (DR)Taiwan
-
Washington University School of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingStrokeUnited States
-
Abbott Medical DevicesNot yet recruitingMitral Regurgitation | Mitral Annulus Calcification | Mitral Valve Disease | Mitral Stenosis | Transcatheter Valve Replacement | Mitral Valve Replacement | Mitral Valve (MV) Regurgitation
-
National Cancer Institute (NCI)Not yet recruitingBurkitt Lymphoma | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
-
AstraZenecaParexelNot yet recruitingGastroesophageal AdenocarcinomaCanada, Italy, Spain, United States, Japan, China, Georgia, Taiwan, Poland, Turkey, United Kingdom
-
AstraZenecaKarolinska Institutet; CTC Clinical Trial Consultants ABRecruitingLiver Fibrosis | Hepatic CirrhosisSweden
-
Boston Scientific CorporationNot yet recruiting
-
Ciceri FabioNot yet recruiting
-
University of SalamancaNot yet recruiting
-
Centre Paul StraussNot yet recruiting
-
Assiut UniversityNot yet recruiting